Saturday marks Day 1 after a patent on Danish healthcare company Novo Nordisks patent on semaglutide expired on March 20 th in India, among other countries
(If you arent confused, Randy Seeley, an obesity researcher at the University of Michigan, told me, you arent paying attention.) In fact, all of these combinations seem to workat least based on preliminary data from clinical trialseven as a precise understanding of the science lags
It also highlights concerns about diabetic retinopathy
Feature details and ratings are based on publicly available App Store listings, Google Play listings, and product information verified June 11, 2026, and may change
Treatment Locations Atherton, CA Auburn, CA Carmichael, CA Citrus Heights, CA Danville, CA El Dorado Hills, CA Fair Oaks, CA Folsom, CA Granite Bay, CA Lafayette, CA Lincoln, CA Los Altos Hills, CA Menlo Park, CA North Highlands, CA Orinda, CA Palo Alto, CA Pleasanton, CA Rancho Cordova, CA Rocklin, CA Roseville, CA Sacramento, CA San Ramon, CA Saratoga, CA Walnut Creek, CA Woodside, CA Blogs Insights, education, and expert guidance to help you take control of your health one article at a time
Some people taking glucagon-like peptide 1 (GLP-1) receptor agonists a type of medication used to support weight loss and manage type 2 diabetes experience gastrointestinal (GI) side effects, including diarrhea